FDA NDC Directory · JSON-LD · Markdown

MVASI

NDC 55513-207 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namebevacizumab-awwb
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA761028
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsBEVACIZUMAB (400 mg/16mL)
Marketing started20180601
Package count2

External sources

Source: openFDA. Public-domain (CC0).